Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Harumi Kato, MD, Naoyuki Tange, MD, Chisako Iriyama, MD PhD, Yuki Kojima, MD, Hirofumi Taji, MD PhD, Tomohiro Kinoshita, MD PhD, Yasushi Yatabe, MD PhD, Shigeo Nakamura, MD PhD, Kazuhito Yamamoto, MDPhD

Blood (2017) 130 (Supplement 1): 4063.

https://doi.org/10.1182/blood.V130.Suppl_1.4063.4063

Published: 2017

Journal Articles

Combination of High Serum Lactate Dehydrogenase Levels at the Time of First Diagnosis and Progression Predicts Early Lymphoma Related Death in Patients with Follicular Lymphoma Receiving R-CHOP Regimen

Satsuki Murakami, Harumi Kato, MD, Kazuhito Yamamoto, MD, PhD, Hirofumi Taji, MD, PhD, Yusuke Higuchi, Yasushi Yatabe, MD, PhD, Shigeo Nakamura, MD, Tmohiro Kinoshita, MD

Blood (2014) 124 (21): 2972.

https://doi.org/10.1182/blood.V124.21.2972.2972

Published: 2014

Journal Articles

Prognostic Value Of GELF Criteria and FLIPI2 For Newly Diagnosed Follicular Lymphoma Receiving R-CHOP Chemotherapy

Satsuki Murakami, M.D., Harumi Kato, M.D, Ph.D., Kazuhito Yamamoto, M.D., Ph.D., Hirofumi Taji, M.D., Ph.D., Daiki Hirano, M.D., Yasushi Yatabe, M.D., Ph.D., Shigeo Nakamura, M.D., Ph.D., Tomohiro Kinoshita, MD, PhD

Blood (2013) 122 (21): 4368.

https://doi.org/10.1182/blood.V122.21.4368.4368

Published: 2013

Journal Articles

Durable Local Disease Control and Survival in Patients with Limited-Stage Diffuse Large B-Cell Lymphoma Receiving Involved-Node Radiation Therapy Plus Short-Course R-CHOP or CHOP Chemotherapy: Involved-Node Versus Involved-Field Radiation Therapy

Harumi Kato, M.D., Ph.D., Takeshi Kodaira, M.D., Ph.D., Kazuhito Yamamoto, M.D., Ph.D., Yukihiko Oshima, M.D., Ph.D., Yasuhiro Oki, M.D., Hiroyuki Tachibana, M.D., Hirofumi Taji, M.D., Ph.D., Satsuki Murakami, M.D., Daiki Hirano, M.D., Natsuo Tomita, M.D., Ph.D., Yasushi Yatabe, M.D., Ph.D., Shigeo Nakamura, M.D., Ph.D., Tomohiro Kinoshita, M.D., Ph.D.

Blood (2012) 120 (21): 3665.

https://doi.org/10.1182/blood.V120.21.3665.3665

Published: 2012

Journal Articles

Gene Expression Profiling of Age-Related Epstein-Barr Virus (EBV)-Associated B-Cell Lymphoproliferative Disorder Uncovers Alterations in Immune and Inflammatory Genes: Possible Implications for Pathogenesis,

Harumi Kato, MD, Kazuhito Yamamoto, MD, PhD, Kennosuke Karube, MD, PhD, Miyuki Katayama, MD, PhD, Shinobu Tsuzuki, MD, PhD, Yasushi Yatabe, MD, PhD, Jun Takizawa, MD, PhD, Koichi Ohshima, MD, PhD, Shigeo Nakamura, MD, PhD, Yasuo Morishima, MD, PhD, Masao Seto, MD, PhD

Blood (2011) 118 (21): 3448.

https://doi.org/10.1182/blood.V118.21.3448.3448

Published: 2011

Journal Articles

Alcohol Drinking, Smoking, Past History of Gastroduodenal Ulcer, Height, and Risk of API2-MALT1 Fusion Positive and Negative Gastric MALT Lymphoma Among Japanese.

Takakazu Kawase, Keitaro Matsuo, Tsuneya Nakamura, Junya Kanda, Hidemi Ito, Satoyo Hosono, Miki Watanabe, Yasushi Yatabe, Yasuo Morishima, Kazuo Tajima, Masao Seto, Shigeo Nakamura, Hideo Tanaka

Blood (2009) 114 (22): 5010.

https://doi.org/10.1182/blood.V114.22.5010.5010

Published: 2009

Journal Articles

Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

Yasushi Yatabe, Ritsuro Suzuki, Kensei Tobinai, Yoshihiro Matsuno, Ryo Ichinohasama, Masataka Okamoto, Motoko Yamaguchi, Jun-ichi Tamaru, Naokuni Uike, Yuko Hashimoto, Yasuo Morishima, Taizan Suchi, Masao Seto, Shigeo Nakamura

Blood (2000) 95 (7): 2253–2261.

https://doi.org/10.1182/blood.V95.7.2253

Published: 2000

Journal Articles

CD7 + and CD56 + Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity

Ritsuro Suzuki, Kazuhito Yamamoto, Masao Seto, Yoshitoyo Kagami, Michinori Ogura, Yasushi Yatabe, Taizan Suchi, Yoshihisa Kodera, Yasuo Morishima, Toshitada Takahashi, Hidehiko Saito, Ryuzo Ueda, Shigeo Nakamura

Blood (1997) 90 (6): 2417–2428.

https://doi.org/10.1182/blood.V90.6.2417

Published: 1997

NARROW

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Combination of High Serum Lactate Dehydrogenase Levels at the Time of First Diagnosis and Progression Predicts Early Lymphoma Related Death in Patients with Follicular Lymphoma Receiving R-CHOP Regimen

Prognostic Value Of GELF Criteria and FLIPI2 For Newly Diagnosed Follicular Lymphoma Receiving R-CHOP Chemotherapy

Durable Local Disease Control and Survival in Patients with Limited-Stage Diffuse Large B-Cell Lymphoma Receiving Involved-Node Radiation Therapy Plus Short-Course R-CHOP or CHOP Chemotherapy: Involved-Node Versus Involved-Field Radiation Therapy

Gene Expression Profiling of Age-Related Epstein-Barr Virus (EBV)-Associated B-Cell Lymphoproliferative Disorder Uncovers Alterations in Immune and Inflammatory Genes: Possible Implications for Pathogenesis,

Alcohol Drinking, Smoking, Past History of Gastroduodenal Ulcer, Height, and Risk of API2-MALT1 Fusion Positive and Negative Gastric MALT Lymphoma Among Japanese.

Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

CD7 + and CD56 + Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only